Physician

Mohammed Rehmani, MD

According to 2025 Medicare claims, Mohammed Rehmani, MD (NPI: 1396840450) practices nephrology in the Rochester, NY market, with the plurality of this provider's patient population coming from Wayne, NY. This provider's primary affiliated billing organization is MOHAMMED S REHMANI INTERNAL MEDICINE PC (NPI: 1881701803; TIN: 522167609) and primary practice location at 14513-1261.

Rehmani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 268 traditional Medicare patients, billed 945 HCPCS/CPT codes, and received $158,291 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,383 prescription claims across 345 beneficiaries totaling $120,034 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2023 DME data shows 12 claims. Open Payments data shows 8 records totaling $284. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $236,270 to $120,034. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	359	1,736	$228,495
2016	362	1,554	$207,682
2017	362	1,693	$232,709
2018	375	1,791	$262,759
2019	408	1,967	$282,073
2020	359	1,746	$256,703
2021	347	1,522	$256,308
2022	316	1,407	$225,575
2023	297	1,184	$189,956
2024	268	945	$158,291

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	402	2,270	$236,270
2016	401	2,483	$396,463
2017	418	2,498	$545,865
2018	423	2,411	$365,217
2019	402	2,334	$300,740
2020	410	2,401	$355,825
2021	428	2,414	$304,166
2022	384	1,739	$221,484
2023	246	1,021	$106,355
2024	345	1,383	$120,034

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$308
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	32	264	$302
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	27	27	$154
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	28	38	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	112	190	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	149	222	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	19	990	$57,431
Sevelamer Carbonate	Sevelamer Carbonate	53	2,667	$15,479
Cinacalcet Hcl	Cinacalcet Hcl	12	1,090	$7,506
Losartan Potassium	Losartan Potassium	314	27,038	$3,649
Calcitriol	Calcitriol	113	9,555	$2,179

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$284	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammed Rehmani, MD?

Tedicare shows public-source Medicare data for Mohammed Rehmani, MD (NPI 1396840450), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammed Rehmani, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohammed Rehmani, MD?

Mohammed Rehmani, MD is linked to MOHAMMED S REHMANI INTERNAL MEDICINE PC (billing NPI 1881701803) in the available physician profile data.

Does Mohammed Rehmani, MD have Open Payments data?

Mohammed Rehmani, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.